title: Letter: Changes in dermoscopic features in superficial basal cell carcinomas treated with imiquimod.
authors.forename: Tamara
authors.initials: T
authors.lastname: Micantonio
authors.forename: Maria Concetta
authors.initials: MC
authors.lastname: Fargnoli
authors.forename: Domenico
authors.initials: D
authors.lastname: Piccolo
authors.forename: Ketty
authors.initials: K
authors.lastname: Peris
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000634:Aminoquinolines / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000473:pathology*; D046169:Dermoscopy / Q000379:methods*; D016903:Drug Monitoring; D004890:Erythema / Q000139:chemically induced; D005260:Female; D006801:Humans; D000077271:Imiquimod; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D012883:Skin Ulcer / Q000139:chemically induced
chemical_list: D000634:Aminoquinolines; D000970:Antineoplastic Agents; D007155:Immunologic Factors; D000077271:Imiquimod